A comparative evaluation of lithium estimation for samples collected in different tubes and its stability on storage

Abstract

PURPOSE: Lithium (Li) is a well-established drug for the treatment of bipolar affective disorders. Li as a drug is known to possess a narrow therapeutic index. Thus, regular monitoring of blood Li in patients receiving Li therapy is essential. Plain tubes with clot activator are known to interfere with Li estimation. The current study was planned to compare Li estimation in sera from vacutainers with clot activator, and plasma from sodium heparinized vacutainers with that of Li estimation in sera from glass vials. The time-dependant stability of Li estimation on storage at 2°C–8°C for 48 h in these three set of tubes was also evaluated.

MATERIALS AND METHODS: Blood from the patients on Li therapy (n = 100) was collected in 3 different collection tubes: plain vacutainer with clot activator (S), Sodium heparinized vacutainer (P) and Glass vial (G) and was analyzed by ion selective electrode (ISE) analyzer for Li levels. Secondary aliquots were also taken from each type of collection tube and stored at 2°C–8°C. Time-dependant stability of Li estimation was checked at 12 h, 24 h, and 48 h. ANOVA followed by Tukey's posttest was performed to calculate statistical significance taking glass vial as reference collection tube. Bland–Altman plots were plotted to compare between three collection tubes at baseline. Stability on storage was defined when >95% of the samples were within allowable error limit for that time point taking baseline levels as reference.

RESULTS: A mean bias of 0.18 mmol/L and mean percentage bias of 19.9% in Li levels was observed between serum from (S) than serum from (G). This difference was found to be statistically significant. However, statistically nonsignificant mean bias of 0.02 mmol/L and mean percentage bias of 3.34% in Li levels was observed between plasma from (P) and serum from (G). Time-dependant stability was observed more in glass vials as compared to vacutainers with clot activator or sodium heparin.

CONCLUSION: Serum from glass vial should be the preferred method for blood collection to determine Li levels.

Key words

Bipolar disorder - ion selective electrode analyser - lithium

Publication History

Received: 25 April 2017

Accepted: 23 July 2017

Article published online:
19 February 2020

• References

• 1 Shorter E. The history of lithium therapy. Bipolar Disord 2009;11 Suppl 2:4-9.
• 2 Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol 1999;10:666-74.
• 3 Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97:383-9.
• 4 O'Keane MP, Cunningham SK. Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: Clinical significance of differences in results and efficiency in use. Clin Chem Lab Med 2006;44:662-8.
• 5 Sampson M, Ruddel M, Albright S, Elin RJ. Positive interference in lithium determinations from clot activator in collection container. Clin Chem 1997;43:675-9.
• 6 CLIA Requirements for Analytical Quality. Available from: http://www.westgard.com'CLIA and Quality'QualityRequirements. [Last accessed on 2015 Jul 30].
• 7 Van Vrancken MJ, Briscoe D, Anderson KM, Wians FJ Jr. Time-dependant stability of 22 analytes in lithium-plasma specimens stored at refrigerator temperature for upto 4 days. Lab Med 2012;43:268-75.
• 8 Boyanton BL Jr., Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002;48:2242-7.
• 9 Dorothea J, White RB, Valerie B. Evaluation of refrigerated stability of 15 analytes in lithium heparin gel primary tubes. Lab Med 2013;44:E45.
• 10 Brown PB, Ligo EF. The estimation of lithium in serum. Ann Clin Biochem 1970;7:13-8.